Meglumine is classified under Antiprotozoals and is sold under the brand name “Omnivist”. It is mostly used to treat leishmaniasis which includes chiclero ulcer, espundia, kala-azar or black sickness, oriental sore, and ulcera de Bejuco which is caused by protozoa. It is administered through the intravenous route. It can cause serious interactions with tobacco and alcohol. The dosage you should take is determined by the strength of this pharmaceutical medicine. The number of doses you take daily, the time between doses, and the length of time you take the medicine depend on the medical problem you are treating with it. It is contraindicated in patients with severe kidney disorders, heart diseases, and/or liver diseases. Common side effects related to this pharmaceutical medicine include fever, irregular heartbeat, nausea, upper abdominal and back pain, vomiting, changes in skin color of the face, cough, allergic reactions, loss of consciousness, husky voice, face swelling, and weakness. It is categorized in pregnancy category C drugs but is not recommended in most countries for pregnant women. It is excreted in breastmilk and a decision is made according to the patient's condition whether to discontinue the drug or continue breastfeeding the child. It was approved in March 2014 by the FDA to treat leishmaniasis.

It works by binding to polypeptides, inhibiting DNA topoisomerase glycolytic enzyme, and inhibiting beta-oxidation of fatty acids.

Meglumine antimoniate costs 1.2 dollars per 5 ml vial of 81mg/ml. This price may fluctuate from seller to seller.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an engaging interface that is easy to navigate through. The selection of Meglumine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters also have the option of filtering according to countries. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Meglumine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Meglumine is already registered in. .

Finding a reliable business partner is one of the most difficult tasks, and the Pipelinepharma website can assist you in locating the most reliable manufacturers and suppliers. As a B2B licensing retail market for pharmaceutical medicines, Pipelinepharma links suppliers with customers to aid in the expansion of their enterprises. Product names can be filtered by country, category, therapeutic area, forms, dossier, and status, as well as regulatory filings, approvals, and more in a user-friendly and unified search engine.

Pipelinepharma is a reputable pharmaceutical firm. The site provides accurate information on the quality of the drug, the length of time it was used, and the identity of the seller. Before being released onto the market, all medication substances are thoroughly tested for potential flaws. The details of the seller are formalized when they join the company to guarantee customers safe and secure services.